10-Q: Green Planet Bioengineering Reports Minimal Activity in Q1 2025, Cites Going Concern Uncertainty

Green Planet Bioengineering Co., Ltd. reports a net loss of $6,840 for the quarter ended March 31, 2025, with continued reliance on related party funding and no active business operations.

Summary

• Green Planet Bioengineering Co., Ltd. filed its Form 10-Q for the quarter ended March 31, 2025.
• The company operates as a public reorganized shell corporation with the aim of acquiring or merging with an existing business.
• For the three months ended March 31, 2025, the company reported a net loss of $6,840, slightly higher than the $6,465 loss in the same period of 2024.
• The company has no active business operations and relies on funding from a related party to cover operating expenses.
• There were no revenues for the periods ended March 31, 2025 and 2024.
• The company's financial statements are prepared under the assumption that it will continue as a going concern, but there is substantial doubt about its ability to do so.
• As of March 31, 2025, the company had a working capital deficit of $471,974 and an accumulated deficit of $1,101,594.
• The company's ability to continue as a going concern depends on continued support from a related party of the majority stockholder.
• The number of common shares outstanding as of May 15, 2025, was 20,006,402.
• The company has no material assets and its liabilities consist primarily of accounts payable and amounts due to a related party.

Sentiment

Score: 2

Explanation: The sentiment is negative due to the company's lack of operations, reliance on related party funding, accumulated deficit, and going concern uncertainty.

Positives

• The company's disclosure controls and procedures are designed at a reasonable assurance level and are effective to provide reasonable assurance that information is recorded, processed, summarized, and reported within specified time periods.
• There were no changes in internal control over financial reporting that materially affected the company's internal control over financial reporting.

Negatives

• The company has no active business operations and is operating as a public reorganized shell corporation.
• The company has a working capital deficit of $471,974 and an accumulated deficit of $1,101,594 as of March 31, 2025.
• The company's ability to continue as a going concern is dependent on continued support from a related party, raising substantial doubt about its future.
• The company reported a net loss of $6,840 for the three months ended March 31, 2025.

Risks

• The company's ability to implement and execute future business plans and generate sufficient business revenue is directly influenced by their ability to secure adequate financing or find profitable business opportunities.
• The company's reliance on a related party for funding poses a risk if that support is discontinued.
• The company's lack of active business operations and accumulated deficit raise concerns about its long-term viability.
• The company's financial statements have been prepared assuming that the Company will continue as going concern, which gives rise to substantial doubt about the Company's ability to continue as a going concern.

Future Outlook

The company will continue to source adequate funding from future investors to execute business opportunities when they arise in the future; however, such funding and business opportunities will rely entirely on the prevailing circumstances when the funding or profitable business opportunities are identified.

Management Comments

• Management believes that the estimates, judgments and assumptions used in preparing the financial statements are reasonable.
• Management concluded that, as of the fiscal period end, the company's disclosure controls and procedures are designed at a reasonable assurance level and are effective.

Industry Context

As a public reorganized shell corporation, Green Planet Bioengineering's situation is not directly comparable to companies with active operations. Shell corporations are often used as vehicles for reverse mergers, and their financial performance prior to a merger is typically minimal.

Comparison to Industry Standards

• It is difficult to compare Green Planet Bioengineering to industry standards due to its status as a shell corporation with no active business operations.
• Typical benchmarks for bioengineering companies, such as research and development spending, revenue growth, and product pipeline progress, are not applicable in this case.
• Comparisons to other shell corporations would be more relevant, but financial data for such entities is often limited and not indicative of future performance after a potential merger.

Related Party Transactions

• The company relies on a related party of the majority stockholder to advance funds to finance its operating expenses.
• The amounts advanced of $466,549 are interest-free, unsecured and are repayable upon demand.

Stakeholder Impact

• Shareholders face significant risk due to the company's lack of operations and going concern uncertainty.
• The company's employees (if any) are subject to job insecurity due to the company's financial situation.
• The company's creditors face risk of non-payment due to the company's financial difficulties.

Next Steps

• The company will seek to identify and execute business opportunities.
• The company will continue to source funding from future investors.

Key Dates

Keywords

going concern, shell corporation, related party, financial statements, net loss, working capital, bioengineering